MDT and patient perspectives on new and emerging therapies for HFrEF

touchMDT for touchCARDIO

Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss established therapies for HFrEF and key efficacy and safety considerations for new and emerging therapies

The multidisciplinary team

• Primary care physician: Prof. Ahmet Fuat, Darlington, UK
• Cardiologist: Dr Akshay Desai, Boston, USA
• Patient: Ms Sarah Worsnop, Hull, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//